Category / Industry news

    Loading posts...
  • OBN BioTuesday: ‘A Spotlight on the Latest Research and Innovation In Cell & Gene Therapy’

    eXmoor to present at OBN BioTuesday: 'A Spotlight on the Latest Research and Innovation In Cell & Gene Therapy' - 21 February eXmoor are delighted to participate in OBN's upcoming  BioTuesday event on 21 February, spotlighting 'Latest Research and Innovation In Cell & Gene Therapy'. During the evening, we will hear from some key thought…
  • eXmoor Pharma appoints CTO as part of ambitious expansion strategy

    eXmoor Pharma appoints CTO as part of ambitious expansion strategy Lucy Foley joins eXmoor after eight years at the Centre for Process Innovation (CPI) with her most recent position as Director of Biologics and COVID response. Bristol, 9th February 2022 - Bristol based, eXmoor Pharma is pleased to announce the appointment of Dr. Lucy Foley…
  • eXmoor Pharma secures contract to work with New Zealand Blood Service

    eXmoor Pharma secures contract to work with New Zealand Blood Service This will be eXmoor’s first project in the Australasia region. The UK-based delivery team has adapted its working processes to allow for collaborative communication across time zones with the NZBS team. 11 January 2021: eXmoor Pharma, experts in strategic and technical biomanufacturing, specialising in…